SCHEMBL7148008

SCHEMBL7148008

C[SH2]c1nc(N)c(C#N)c(-c2cccs2)c1C#N

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 11/20 0.58
ALDH1A1 P00352 10/20 0.58
MEN1 O00255 7/20 0.58
KMT2A Q03164 7/20 0.58
MAPT P10636 7/20 0.55
NPSR1 Q6W5P4 5/20 0.55
HPGD P15428 4/20 0.55
HTT P42858 3/20 0.55
GAA P10253 2/20 0.55
STAT6 P42226 1/20 0.55
HIF1A Q16665 1/20 0.55
CYP1A2 P05177 1/20 0.55
CYP2C9 P11712 1/20 0.55
CYP2C19 P33261 1/20 0.55
ADORA1 P30542 5/20 0.54
ADORA3 P0DMS8 1/20 0.54
ADORA2B P29275 1/20 0.54
ADORA2A P29274 3/20 0.53
PIM1 P11309 1/20 0.53
HSD17B10 Q99714 5/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7013616 0.78 KDM4E (0.56) KDM4EALDH1A1MEN1KMT2AMAPT
SCHEMBL1029261 0.78 KDM4E (0.60) KDM4EALDH1A1MEN1KMT2AMAPT
SCHEMBL7013904 0.78 KDM4E (0.58) KDM4EALDH1A1MEN1KMT2AMAPT
SCHEMBL6442951 0.78 KDM4E (0.68) KDM4EALDH1A1MEN1KMT2AMAPT
SCHEMBL6256897 0.72 KDM4E (1.00) KDM4EALDH1A1MEN1KMT2ANPSR1
SCHEMBL28184878 0.71 KDM4E (0.71) KDM4EALDH1A1MEN1KMT2AMAPT
SCHEMBL6252553 0.71 KDM4E (0.97) KDM4EALDH1A1MEN1KMT2ANPSR1
SCHEMBL1539801 0.71 MAPT (0.57) KDM4EALDH1A1MEN1KMT2AMAPT
SCHEMBL7016994 0.70 ADORA1 (1.00) KDM4EALDH1A1MEN1KMT2AMAPT
SCHEMBL1028666 0.70 ALDH1A1 (0.80) KDM4EALDH1A1MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6586441-B2 2-Amino-6-benzylsulfanyl-4-thiophen-2-yl-pyridine-3,5-dicarbo -nitrile as an examplary preferred compound; Alzheimer's and Parkinson's diseases; neuroprotectors; schizophrenia, analgesics; anxiolytic agents; respiratory disorders HOFFMAN-LA ROCHE INC. 2003-07-01 US disclosed
US-20010027196-A1 Adenosine receptor ligands and their use in the treatment of disease F. HOFFMANN-LA ROCHE AG (CH) 2001-10-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010027196-A1 Adenosine receptor ligands and their use in the treatment of disease ADORA2A, ADORA2B, ADORA1 KDM4E 3250/4885ALDH1A1 534/4885MEN1 4860/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.